Product code KLT— Clinical Toxicology

EMIT CARBAMAZEPINE ASSAY

Classification name
Enzyme Immunoassay, Carbamazepine
Device class
Class 2
Regulation
21 CFR 862.3645
Advisory panel
Clinical Toxicology
Total cleared
56
First cleared
Most recent

Market context for product code KLT

FDA has cleared 56 devices under product code KLT between 1978 and 2015, filed by 34 applicant companies. No FDA device recalls reference this product code. Class II devices are moderate-risk and subject to general and special controls; most reach market through 510(k) clearance by demonstrating substantial equivalence to a predicate device.

Clearances per year

last 15 years

Top applicants under product code KLT

Recent clearances under product code KLT

Data sourced from openFDA. This site is unofficial and independent of the FDA.